CGK012对抗脂聚糖诱导炎症的有益作用

Jinhee Lee1, Jong Beom Heo2, Hae Joon Heo2

  • 1College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Republic of Korea.

Journal of medicinal food
|February 3, 2025
PubMed
概括

作为Wnt/β-catenin抑制剂的CGK012,通过增加血红素酶-1和降低iNOS和TNF-α等炎症标志物来降低炎症. 这表明炎症性疾病的治疗潜力.